Short telomeres and chromosome instability prior to histologic malignant progression and cytogenetic aneuploidy in papillary urothelial neoplasms

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 2, 2014, Pages 135-145

  Izumiyama Shimomura, Naotaka ^a   Nakamura, Ken ichi ^a   Aida, Junko ^a,h   Ishikawa, Naoshi ^a   Kuroiwa, Mie ^b   Hiraishi, Naoki ^c   Fujiwara, Mutsunori ^d   Ishikawa, Yuichi ^e   Inoshita, Naoko ^e   Yonese, Junji ^f   Matsuura, Masaaki ^e   Poon, Steven S S ^g   Arai, Tomio ^h   Takubo, Kaiyo ^a,h  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b YOKOHAMA COLLEGE OF PHARMACY   (Japan)

^c JAPANESE RED CROSS SOCIETY   (Japan)

^d JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^e CANCER INSTITUTE   (Japan)

^f CANCER INSTITUTE HOSPITAL   (Japan)

^g BRITISH COLUMBIA CANCER AGENCY   (Canada)

^h Tokyo Metropolitan Institute of Gerontology   (Japan)

Author keywords

Anaphase bridge; Chromosomal instability; Karyotype analysis; PUNLMP; Q FISH; Telomere; Urothelial carcinoma

Indexed keywords

ADULT; AGED; ANAPHASE; ANEUPLOIDY; ARTICLE; CANCER GROWTH; CHROMOSOMAL INSTABILITY; CLINICAL ARTICLE; CYTOGENETICS; DIPLOIDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HIGH GRADE PAPILLARY UROTHELIAL CARCINOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; KARYOTYPING; LOW GRADE PAPILLARY UROTHELIAL CARCINOMA; MALE; MIDDLE AGED; PAPILLARY UROTHELIAL NEOPLASM OF LOW MALIGNANT POTENTIAL; POLYPLOIDY; PRIORITY JOURNAL; TELOMERE SHORTENING; TRANSITIONAL CELL CARCINOMA; VERY ELDERLY;

ANAPHASE BRIDGE; CHROMOSOMAL INSTABILITY; KARYOTYPE ANALYSIS; PUNLMP; Q-FISH; TELOMERE; UROTHELIAL CARCINOMA;

AGED; AGED, 80 AND OVER; ANAPHASE; ANEUPLOIDY; CARCINOMA, PAPILLARY; CARCINOMA, TRANSITIONAL CELL; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMAL INSTABILITY; CYTOGENETIC ANALYSIS; DISEASE PROGRESSION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPE; MIDDLE AGED; SPECTRAL KARYOTYPING; TELOMERE; TELOMERE SHORTENING; UROLOGIC NEOPLASMS;

EID: 84892517199     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2012.12.005     Document Type: Article

References (36)

1. Castillo-Martin M., Domingo-Domenech J., Karni-Schmidt O., et al. Molecular pathways of urothelial development and bladder tumorigenesis. Urol Oncol 2010, 28(4):401-408.
2. Goebell P.J., Knowles M.A. Bladder cancer or bladder cancers? genetically distinct malignant conditions of the urothelium. Urol Oncol 2010, 28(4):409-428.
3. McConkey D.J., Lee S., Choi W., et al. Molecular genetics of bladder cancer: emerging mechanisms of tumor initiation and progression. Urol Oncol 2010, 28(4):429-440.
4. Mitra A.P., Cote R.J. Molecular pathogenesis and diagnostics of bladder cancer. Annu Rev Pathol 2009, 4:251-285.
5. Pollard C., Smith S.C., Theodorescu D. Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC). Expert Rev Mol Med 2010, 12:e10.
6. Juan R. Urothelial (transitional cell) carcinoma. Rosai and Ackerman's surgical pathology 2011, Elsevier, Edinburgh, London, New York, Oxford, Philadelphia, St Louis, Sydney, Toronto, p. 1257-66. 10th ed.
7. Lopez-Beltran A., Knowles M.A., Sauter G., et al. Tumours of the urinary system 2004, IARC Press, Lyon.
8. Greider C.W. Telomeres and senescence: the history, the experiment, the future. Curr Biol 1998, 8:R178-R181.
9. de Lange T. Telomeres and senescence: ending the debate. Science 1998, 279:334-335.
10. Harley C.B., Villeponteau B. Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev 1995, 5:249-255.
11. McGrath M., Wong J.Y., Michaud D., et al. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 2007, 16:815-819.
12. Rudlph K.L., Millard M., Bosenberg M.W., et al. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet 2001, 28:155-159.
13. Gisselsson D., Pettersson L., Hoglund M., et al. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc Natl Acad Sci USA 2000, 97:5357-5362.
14. Poon S.S., Lansdorp P.M. Measurements of telomere length on individual chromosomes by image cytometry. Methods in cell biology, flow cytometry 2001, 69-96. Academic Press, San Diego, CA. Z. Darzynkiewicz, H.A. Crissman, J.P. Robinson (Eds.).
15. Takubo K., Aida J., Izumiyama N., et al. Chromosomal instability and telomere lengths of each chromosomal arm measured by Q-FISH in human fibroblast strains prior to replicative senescence. Mech Ageing Dev 2010, 131:614-624.
16. Epstein J.I., Amin M.B., Reuter V.R., et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder consensus conference committee. Am J Surg Pathol 1998, 22:1435-1448.
17. Miura I., Siegfried J.M., Resau J., et al. Chromosome alterations in 21 non-small cell lung carcinomas. Genes Chromosomes Cancer 1990, 2:328-338.
18. Shaffer LG, Slovak ML, Campbell LJ. An international system for human cytogenetic nomenclature: recommendations of the international standing committee on human cytogenetic nomenclature. Basel: S. Karger Co., 2009.
19. Poon S.S., Lansdorp P.M. Quantitative fluorescence in situ hybridization (Q-FISH). Curr Protoc Cell Biol 2001, 18:4. Chapter 18 Unit.
20. Eble JN, Sauter G, Epstein JI, et al. World Health Organization Classification of Tumours. Pathology and genetics of tumours of the urinary system and male genital organs. TNM classification of carcinomas of the urinary bladder. Lyon: IARC Press: 2004. p. 91.
21. Montironi R., Lopez-Beltran A. The 2004 WHO classification of bladder tumors: a summary and commentary. Int J Surg Pathol 2005, 13:143-153.
22. Micic S., Micic M., Milasin J. Chromosome analysis in patients with bladder tumor. Urol Int 1988, 43(4):201-204.
23. Bartlett J.M., Adie L., Watters A.D., et al. Chromosomal aberrations in transitional cell carcinoma that are predictive of disease outcome are independent of polyploidy. BJU Int 1999, 84:775-779.
24. Malmstrom P.U., Busch C., Norlen B.J. Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up. Scand J Urol Nephrol 1987, 21:185-195.
25. Wu X., Amos C.I., Zhu Y., et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst 2003, 95:1211-1218.
26. Gu J., Chen M., Shete S., et al. A genome-wide association study identifies a locus on chromosome 14q21 as a predictor of leukocyte telomere length and as a marker of susceptibility for bladder cancer. Cancer Prev Res 2011, 4:514-521.
27. Broberg K., Bjork J., Paulsson K., et al. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis 2005, 26:1263-1271.
28. Kamata S., Kageyama Y., Yonese J., et al. Significant telomere reduction in human superficial transitional cell carcinoma. Br J Urol 1996, 78:704-708.
29. Sanada Y., Aida J., Kawano Y., et al. Hepatocellular telomere length in biliary atresia measured by Q-FISH. World J Surg 2012, 36:908-916.
30. Oexle K. Telomere length distribution and Southern blot analysis. J Theor Biol 1998, 190:369-377.
31. O'Sullivan J.N., Bronner M.P., Brentnall T.A., et al. Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet 2002, 32:280-284.
32. Takubo K., Fujita M., Izumiyama N., et al. Q-FISH analysis of telomere and chromosome instability in the oesophagus with and without squamous cell carcinoma in situ. J Pathol 2010, 221:201-209.
33. Aida J., Izumo T., Shimomura N., et al. Telomere lengths in the oral epithelia with and without carcinoma. Eur J Cancer 2010, 46:430-438.
34. Greider C.W. Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci USA 1998, 95:90-92.
35. Lansdorp P.M., Verwoerd N.P., van de Rijke F.M., et al. Heterogeneity in telomere length of human chromosomes. Hum Mol Genet 1996, 5:685-691.
36. Sandell L.L., Zakian V.A. Loss of a yeast telomere: arrest, recovery, and chromosome loss. Cell 1993, 75:729-739.